Emerging market equities have suffered another decade of underperformance versus developed markets. Recently, their underperformance has been more marked relative to US markets than the rest of the world. With sentiment having already brightened in developed markets as the COVID-19 lockdowns are eased, and valuations, particularly in the technology sector, having become elevated, this may be a good time to rotate into EM equities.
In the near term, the commodity-sensitive Latin America and EMEA regions should outperform as crude oil and metal prices continue to recover, while equity markets in China may lag due to US election-related political tensions.
Over the medium term, however, the effects of China’s large fiscal boost to the economy should feed through to the rest of the region and the dominance of Asia, and in particular of Chinese technology, should reassert itself.
The long-term drivers of emerging market equity outperformance are well known:
While these are all generally true, the market has moved to its own rhythms. Since 1975, periods of EM outperformance and underperformance have cycled over roughly 10-year spans, with the latest wave of underperformance beginning in 2010.
The most recent period is unique, however, in that since 2013, the underperformance of EM has been largely against the US, while against the rest of developed market equities, returns have been in line.
As with so many markets these days, the technology sector explains much, though not all, of the divergence in performance. Emerging markets have underperformed the US in most sectors, including
Compared to developed market equities excluding the US, the lagging sectors are similar with the significant exception of IT. Given the low weight of tech in the MSCI World ex-US index, the outperformance of emerging markets tech easily offsets the losses in the other sectors, leading to a flat performance overall (see Exhibit 1).
At least in the near term, there are reasons to believe this may be the case. Developed countries have largely passed through the worst of the coronavirus pandemic and are in the process of managing their exit from lockdowns. While we expect one, or several, second waves, it is unlikely nationwide restrictions will be imposed to the same degree. One reason is that the economic cost may be prohibitive.
Also, with the knowledge gained over the last several months about the effects of the virus, we now know that vulnerable populations (notably those over 55, who have accounted for 93% of deaths in the US), can be protected without having to confine children and a vast share of the working age population.
Developed market equity performance has also ready reflected this comparatively more optimistic outlook, however, since March. By contrast, many emerging markets are either still in some stage of lockdown or only slowly exiting them, often unwillingly, and the economic rebound has yet to occur. Another reason for optimism is the outsized fiscal and monetary stimulus in China, which is nearly on par with the stimulus in 2015-2016. If history is any guide, this support should not only benefit the Chinese economy, but also other emerging markets, though in 2015-2016, it took several months before the relative performance of the markets reflected the impact (see Exhibit 2).
Valuations are a further factor in favour of emerging markets. The price-book ratio of the MSCI EM index relative to that of the MSCI World index is near the lows since 2003. For the IT sector, relative multiples have rarely been this low since the tech bubble in the late 1990s.
On a price-to-next-twelve-month (NTM) earnings basis, relative multiples are similarly near levels not often seen since 2005 after which there was an extended period of EM outperformance.
Ahead of November’s US presidential election, it is reasonable to expect heightened anti-China and anti-trade rhetoric from President Donald Trump. During the worst of the trade war, emerging markets and particularly China underperformed the US. That said, the political calculation could also support at least another interim resolution as a rising stock market could still be one of Trump’s strongest claims to re-election.
The economic rebound in emerging markets ex-China may not be as strong as that in the developed world as most emerging markets do not have the same capacity for fiscal or monetary stimulus.
The collapse of many EM currencies, while helping exporters, will pose a problem for companies with significant hard currency debts.
Moreover, weaker currencies will be of less benefit to exporters when global trade is likely to remain subdued and many developed countries wish to re-shore production. We will address some of these nuances in the part two.
This material is issued by BNP PARIBAS ASSET MANAGEMENT UK Limited (“BNPPAM UK”). BNPPAM UK is authorised and regulated by the Financial Conduct Authority. Registered in England No: 02474627, registered office: 5 Aldermanbury Square, London, England, EC2V 7BP, United Kingdom. In Australia, BNPPAM UK is exempt from the requirement to hold an Australian financial services license under the Corporations Act 2001 in respect of the financial services. BNPPAM UK is regulated by the FCA under UK laws, which differ from Australian laws. This document is distributed in Australia by BNP PARIBAS ASSET MANAGEMENT Australia Limited ABN 78 008 576 449, AFSL 223418.
This material is produced for information purposes for wholesale Investors only and does not constitute:
1. an offer to buy nor a solicitation to sell, nor shall it form the basis of or be relied upon in connection with any contract or commitment whatsoever or
2. investment advice.
This material makes reference to certain financial instruments authorised and regulated in their jurisdiction(s) of incorporation.
No action has been taken which would permit the public offering of the financial instrument(s) in any other jurisdiction, except as indicated in the most recent prospectus and the Key Investor Information Document (KIID) of the relevant financial instrument(s) where such action would be required, in particular, in the United States, to US persons (as such term is defined in Regulation S of the United States Securities Act of 1933). Prior to any subscription in a country in which such financial instrument(s) is/are registered, investors should verify any legal constraints or restrictions there may be in connection with the subscription, purchase, possession or sale of the financial instrument(s).
The value of investments and the income they generate may go down as well as up and it is possible that investors will not recover their initial outlay.
Investing in emerging markets, or specialised or restricted sectors is likely to be subject to a higher than average volatility due to a high degree of concentration, greater uncertainty because less information is available, there is less liquidity, or due to greater sensitivity to changes in market conditions (social, political and economic conditions).
Some emerging markets offer less security than the majority of international developed markets. For this reason, services for portfolio transactions, liquidation and conservation on behalf of funds invested in emerging markets may carry greater risk.
Opinions included in this material constitute the judgement of the investment management company at the time specified and may be subject to change without notice. The investment management company is not obliged to update or alter the information or opinions contained within this material. Investors should consult their own legal and tax advisors in respect of legal, accounting, domicile and tax advice prior to investing in the financial instrument(s) in order to make an independent determination of the suitability and consequences of an investment therein, if permitted. Please note that different types of investments, if contained within this material, involve varying degrees of risk and there can be no assurance that any specific investment may either be suitable, appropriate or profitable for an investor’s investment portfolio.
Given the economic and market risks, there can be no assurance that the financial instrument(s) will achieve its/their investment objectives. Returns may be affected by, amongst other things, investment strategies or objectives of the financial instrument(s) and material market and economic conditions, including interest rates, market terms and general market conditions. The different strategies applied to financial instruments may have a significant effect on the results presented in this material. Past performance is not a guide to future performance and the value of the investments in financial instrument(s) may go down as well as up. Investors may not get back the amount they originally invested. The performance data, as applicable, reflected in this material, do not take into account the commissions, costs incurred on the issue and redemption and taxes.